Newsletters

Newsletters published on February 13, 2020

This newsletter discusses approaches to inhibit JAK2, as well as other combination approaches with ruxolitinib to maximize efficacy for patients with myelofibrosis.

For more information on managing your patients with myelofibrosis, please view the CE Education activity here

Newsletters published on December 10, 2019
This newsletter discusses classic myeloproliferative neoplasms, such as ET, PV and PMF; including how they interact, evolve and what treatment selections are available.

For more information on managing your patients with myelofibrosis, please view the CE Education activity here


Results 1 - 2 of 2